Medicenna Therapeutics Corp. Depreciation Expense
Medicenna Therapeutics Corp. (MDNAF) reported Depreciation Expense of CAD 5.00 thousand for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2023-06-27
| Period end | Depreciation Expense 12 month |
|---|---|
| 2023-03-31 | 5.00K CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 37.00K CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 40.00K CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 8.00K CAD 20-F · filed 2022-06-22 |